Table 4 Effect of inhibitor development, treatment type, haemophilia severity and drugs use on the variance

Physical functioning

2.67

81

0.28

-1.25

81

0.13

3.98

81

0.40 ^b

4.52

81

0.44 ^b

Role-physical

2.57

81

0.27

-2.29

81

0.24

2.82

81

0.29

7.39

80.65

0.63 ª

Body pain

1.33

81

0.14

-1.63

81

0.17

2.76

81

0.29

6.56

81

0.58 ª

General health

0.42

81

0.04

− 0.98

81

0.10

3.15

81

0.33

4.01

81

0.40 ^b

Vitality

0.86

81

0.09

0.16

29.23

0.03

2.55

81

0.27

5.90

75.94

0.56 ª

Social functioning

1.14

81

0.12

− 0.20

81

0.02

2.20

81

0.23

3.75

81

0.38 ^b

Role-emotional

− 0.16

81

0.01

− 0.34

81

0.03

3.29

70.0

0.36 ^b

3.34

57.0

0.40 ^b

Mental health

0.34

81

0.03

− 0.32

81

0.03

4.14

37.28

0.56 ª

5.71

79.81

0.29

Physical component score

2.45

81

0.26

-1.86

81

0.20

3.91

81

0.39 ^b

7.13

64.08

0.66 ª

Mental component score

− 0.81

81

0.08

0.88

81

0.09

0.67

81

0.07

1.67

81

0.28